AUMED, established in 2007, specializes in the research and development of innovative immunobiological preparations and pharmaceuticals. Initially focused on other industries, the company shifted to healthcare and pharmaceuticals in response to market demands. Today, AUMED drives pioneering research in advanced treatments, particularly in phage therapy. Its subsidiaries, AUMED Immunology a.s. and Aumed Pharma a.s., further enhance its impact in improving patient care and developing breakthrough therapies for conditions like acne and atopic eczema.
Company Details
- Employees
- 8
- Address
- Komořanská, Praha 12,prague 143 00,czech Republic
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.aumed.cz
- Keywords
- Praha 6.
- HQ
- Praha 12, Prague
Aumed A.s. Questions
Aumed A.S.'s website is http://www.aumed.cz
Aumed A.S.'s LinkedIn profile is https://cz.linkedin.com/company/aumed-as
Aumed A.S. has
8 employees.
View email and phone details for 8
employees at Aumed A.S..
Aumed A.S.'s industry is
Pharmaceutical Manufacturing
Aumed A.S.'s top competitors are
Human Bioplazma Kft.,
Czepar - Česká Platforma Antibiotické Rezistence,
Hays,
Ibadan Bacteriophage Research Team,
Elisabeth Pharmacon,
Deltamed Cro,
Profam Health,
Jafral Biosolutions,
Phage Europe,
Naturamed.
Aumed A.S.'s categories are Pharmaceutical Manufacturing
